Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
about
Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivorsQuantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.Neurocognitive functioning in adult survivors of childhood non-central nervous system cancers.Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction.Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemiaCognitive reserve and brain volumes in pediatric acute lymphoblastic leukemia.Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort StudyImpact of chemotherapy for childhood leukemia on brain morphology and function.Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemiaNeurocognitive outcome in survivors of childhood acute lymphoblastic leukemia: experience at a tertiary care hospital in Korea.Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence?Population-based exploration of academic achievement outcomes in pediatric acute lymphoblastic leukemia survivors.Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic LeukemiaNeurodevelopmental functioning in very young children undergoing treatment for non-CNS cancersOxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia SurvivorsCognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy ProtocolPuppets, robots, critics, and actors within a taxonomy of attention for developmental disordersA comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptomsBrain structure, working memory and response inhibition in childhood leukemia survivors.Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical modelsLate effects of childhood leukemia therapy.Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on MethotrexateMonitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study.The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review.Ninth grade school performance in Danish childhood cancer survivors.Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.Types and Influence of Social Support on School Engagement of Young Survivors of Leukemia.
P2860
Q26825655-132D0D97-E367-4979-9521-1F8E5A97BDB6Q33291796-E2C3673A-BED5-4B1C-A8DF-1C91B26C722AQ33739935-E9BF9411-0E1E-4B90-AE63-3D18A062BD86Q33915042-1958254F-679B-4D36-B165-8A4F8FBC0C87Q34396479-F751C746-2E8E-4E76-B496-80C06A10BAB9Q34498685-A7AA8662-1709-4F42-8CC5-9E2E5EC94087Q34630002-9035A16C-D62B-4A37-B80B-3994E784F908Q35002237-1D14CE2A-F9FE-4723-B95E-79FB4B20043DQ35050321-3284EAA8-9FE0-4294-B2FA-040656DF027FQ35076156-3E245545-3954-401C-B157-6BD1FA2C1F77Q35098712-B5DEDC2A-CB4F-4D07-AA07-29CD828DEACAQ35119007-D31B335C-89D3-416F-9C4A-D30D2CC15B33Q35198585-A2AFDDFF-4798-4231-8D6F-788EC7F1BA59Q35580998-A2F0EC75-A0F5-4B63-B0D5-91976C1F9295Q35736047-55EC95CC-88EB-4517-89E2-24231BC21A91Q35907493-F4AE7515-463F-4BDD-B6D7-D9054BDD6D9CQ35999979-53D484D4-4F62-4575-87F0-8B2961A1CD53Q36054142-DE385AA2-7BC3-4184-BC86-025764C7987AQ36082861-7E62ABC2-BAA7-421B-A793-19419F1AC0E1Q36445713-1D2A6180-485A-478C-9771-445E5963695AQ36486782-512A8230-6798-41C3-8FFF-451C3B7D9476Q36576663-351B3C37-7727-485D-8A3D-A2C94C94EA6EQ36915213-E5B73A1D-0D0C-4A77-8F85-1738D026B093Q36994206-9F41FA86-C24D-42F9-ADF0-F24150A1BA54Q37334592-21F293FA-EC7D-46DC-B777-0C6941C591C7Q37474408-CDD3460F-BBA7-4BC8-97C7-724687D6B249Q37641257-3D225BAA-7061-479B-884C-8B8DC4DB62F0Q37653619-B15EA8B4-3DE8-41D6-B3A5-AEEFF5299B60Q37727506-993A9ED3-4907-49B9-B87F-C4D35EC313A9Q37879488-DAE47DBF-DC73-4613-B7D7-24217CF15C20Q37892981-8D1F898C-F2D1-4D41-B3BA-CA4BB4DCC8F3Q38188526-4CDEB08B-F10E-4BCA-8848-8BA803B10BBBQ38580062-088E0BAA-AB99-40E9-90E6-26E68409057EQ38678301-F65C6E64-8FA6-490D-B207-19609F57B6FFQ38813392-18834E49-9F6D-4546-A439-3F63F2C86F4DQ38820168-423E4CB1-7732-4362-B97D-A23897F8E7BAQ38970742-75546F60-2307-4E5A-8207-C82F980B1E36Q39024250-83127A97-6F68-4C07-A089-85F8F3083BF9Q39303835-14EF38B5-8B95-491B-BA6C-13552F31B14DQ39892886-6FDCB21C-11F2-408B-B928-07AD794B230A
P2860
Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Chemotherapy and attentional d ...... effect of treatment intensity.
@en
type
label
Chemotherapy and attentional d ...... effect of treatment intensity.
@en
prefLabel
Chemotherapy and attentional d ...... effect of treatment intensity.
@en
P921
P356
P1476
Chemotherapy and attentional d ...... effect of treatment intensity
@en
P2093
Anjo J P Veerman
Marry M van den Heuvel-Eibrink
P304
P356
10.1002/PBC.20397
P577
2005-09-01T00:00:00Z